Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.88 Billion USD | -22.35% |
| 2022 | 3.71 Billion USD | 104.24% |
| 2021 | 1.81 Billion USD | 16.7% |
| 2020 | 1.55 Billion USD | 2.77% |
| 2019 | 1.51 Billion USD | 38.42% |
| 2018 | 1.09 Billion USD | 42.96% |
| 2017 | 766.62 Million USD | 11.77% |
| 2016 | 685.9 Million USD | -9.71% |
| 2015 | 759.65 Million USD | -2.36% |
| 2014 | 778.03 Million USD | 5.6% |
| 2013 | 736.76 Million USD | -0.7% |
| 2012 | 741.96 Million USD | 16.55% |
| 2011 | 636.62 Million USD | 22.85% |
| 2010 | 518.22 Million USD | 25.38% |
| 2009 | 413.32 Million USD | -37.72% |
| 2008 | 663.63 Million USD | -34.61% |
| 2007 | 1.01 Billion USD | 2.24% |
| 2006 | 992.57 Million USD | 59.05% |
| 2005 | 624.08 Million USD | -7.0% |
| 2004 | 671.03 Million USD | 36.2% |
| 2003 | 492.7 Million USD | -25.06% |
| 2002 | 657.49 Million USD | -6.58% |
| 2001 | 703.83 Million USD | 37.16% |
| 2000 | 513.12 Million USD | 189.74% |
| 1999 | 177.1 Million USD | 25.6% |
| 1998 | 141 Million USD | -5.81% |
| 1997 | 149.7 Million USD | 131.02% |
| 1996 | 64.8 Million USD | 27.56% |
| 1995 | 50.8 Million USD | 296.88% |
| 1994 | 12.8 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.32 Billion USD | -9.37% |
| 2024 Q2 | 2.56 Billion USD | -9.23% |
| 2024 Q1 | 2.82 Billion USD | -2.13% |
| 2023 Q1 | 3.29 Billion USD | -11.4% |
| 2023 Q4 | 2.88 Billion USD | -5.98% |
| 2023 Q2 | 3.24 Billion USD | -1.29% |
| 2023 Q3 | 3.06 Billion USD | -5.55% |
| 2023 FY | 2.88 Billion USD | -22.35% |
| 2022 Q4 | 3.71 Billion USD | -0.18% |
| 2022 FY | 3.71 Billion USD | 104.24% |
| 2022 Q1 | 1.85 Billion USD | 1.95% |
| 2022 Q2 | 4.15 Billion USD | 124.24% |
| 2022 Q3 | 3.72 Billion USD | -10.5% |
| 2021 Q4 | 1.81 Billion USD | 3.19% |
| 2021 Q1 | 1.61 Billion USD | 3.57% |
| 2021 FY | 1.81 Billion USD | 16.7% |
| 2021 Q2 | 1.66 Billion USD | 3.06% |
| 2021 Q3 | 1.76 Billion USD | 5.96% |
| 2020 Q1 | 1.55 Billion USD | 2.76% |
| 2020 Q2 | 1.47 Billion USD | -5.11% |
| 2020 Q3 | 1.5 Billion USD | 1.66% |
| 2020 Q4 | 1.55 Billion USD | 3.67% |
| 2020 FY | 1.55 Billion USD | 2.77% |
| 2019 Q1 | 1.49 Billion USD | 36.56% |
| 2019 Q4 | 1.51 Billion USD | 1.62% |
| 2019 FY | 1.51 Billion USD | 38.42% |
| 2019 Q3 | 1.49 Billion USD | 0.33% |
| 2019 Q2 | 1.48 Billion USD | -0.59% |
| 2018 Q1 | 987.67 Million USD | 28.83% |
| 2018 FY | 1.09 Billion USD | 42.96% |
| 2018 Q4 | 1.09 Billion USD | 0.42% |
| 2018 Q3 | 1.09 Billion USD | 2.33% |
| 2018 Q2 | 1.06 Billion USD | 7.98% |
| 2017 Q4 | 766.62 Million USD | 2.66% |
| 2017 FY | 766.62 Million USD | 11.77% |
| 2017 Q1 | 692.3 Million USD | 0.93% |
| 2017 Q2 | 722.17 Million USD | 4.31% |
| 2017 Q3 | 746.77 Million USD | 3.41% |
| 2016 Q2 | 684.39 Million USD | -8.63% |
| 2016 Q4 | 685.9 Million USD | 0.53% |
| 2016 FY | 685.9 Million USD | -9.71% |
| 2016 Q1 | 749.03 Million USD | -1.4% |
| 2016 Q3 | 682.32 Million USD | -0.3% |
| 2015 Q1 | 757.14 Million USD | -2.69% |
| 2015 Q2 | 756.95 Million USD | -0.03% |
| 2015 Q3 | 770.37 Million USD | 1.77% |
| 2015 Q4 | 759.65 Million USD | -1.39% |
| 2015 FY | 759.65 Million USD | -2.36% |
| 2014 FY | 778.03 Million USD | 5.6% |
| 2014 Q4 | 778.03 Million USD | -2.26% |
| 2014 Q1 | 729.66 Million USD | -0.96% |
| 2014 Q2 | 767.22 Million USD | 5.15% |
| 2014 Q3 | 796 Million USD | 3.75% |
| 2013 Q3 | 720.43 Million USD | -0.18% |
| 2013 Q2 | 721.76 Million USD | -0.42% |
| 2013 Q1 | 724.82 Million USD | -2.31% |
| 2013 FY | 736.76 Million USD | -0.7% |
| 2013 Q4 | 736.76 Million USD | 2.27% |
| 2012 Q1 | 621.8 Million USD | -2.33% |
| 2012 Q2 | 636.67 Million USD | 2.39% |
| 2012 Q3 | 645.32 Million USD | 1.36% |
| 2012 Q4 | 741.96 Million USD | 14.97% |
| 2012 FY | 741.96 Million USD | 16.55% |
| 2011 Q1 | 536.57 Million USD | 3.54% |
| 2011 FY | 636.62 Million USD | 22.85% |
| 2011 Q3 | 626.35 Million USD | 10.8% |
| 2011 Q2 | 565.28 Million USD | 5.35% |
| 2011 Q4 | 636.62 Million USD | 1.64% |
| 2010 Q1 | 429.69 Million USD | 3.96% |
| 2010 FY | 518.22 Million USD | 25.38% |
| 2010 Q4 | 518.22 Million USD | 5.13% |
| 2010 Q3 | 492.93 Million USD | 4.43% |
| 2010 Q2 | 472 Million USD | 9.85% |
| 2009 FY | 413.32 Million USD | -37.72% |
| 2009 Q1 | 615.26 Million USD | -7.29% |
| 2009 Q2 | 445.09 Million USD | -27.66% |
| 2009 Q3 | 417.08 Million USD | -6.29% |
| 2009 Q4 | 413.32 Million USD | -0.9% |
| 2008 Q1 | 958.78 Million USD | -5.52% |
| 2008 Q2 | 909.8 Million USD | -5.11% |
| 2008 Q3 | 888.66 Million USD | -2.32% |
| 2008 Q4 | 663.63 Million USD | -25.32% |
| 2008 FY | 663.63 Million USD | -34.61% |
| 2007 Q2 | 1.09 Billion USD | 9.29% |
| 2007 Q1 | 999.69 Million USD | 0.72% |
| 2007 FY | 1.01 Billion USD | 2.24% |
| 2007 Q4 | 1.01 Billion USD | -9.0% |
| 2007 Q3 | 1.11 Billion USD | 2.07% |
| 2006 Q4 | 992.57 Million USD | -12.29% |
| 2006 Q2 | 1.1 Billion USD | 2.53% |
| 2006 Q1 | 1.08 Billion USD | 73.47% |
| 2006 FY | 992.57 Million USD | 59.05% |
| 2006 Q3 | 1.13 Billion USD | 1.95% |
| 2005 Q1 | 652.14 Million USD | -2.82% |
| 2005 Q2 | 646.29 Million USD | -0.9% |
| 2005 Q3 | 640.46 Million USD | -0.9% |
| 2005 FY | 624.08 Million USD | -7.0% |
| 2005 Q4 | 624.08 Million USD | -2.56% |
| 2004 Q2 | 652.98 Million USD | 7.09% |
| 2004 Q4 | 671.03 Million USD | 1.91% |
| 2004 Q3 | 658.44 Million USD | 0.84% |
| 2004 FY | 671.03 Million USD | 36.2% |
| 2004 Q1 | 609.74 Million USD | 23.76% |
| 2003 Q3 | 547.71 Million USD | -3.6% |
| 2003 FY | 492.7 Million USD | -25.06% |
| 2003 Q4 | 492.7 Million USD | -10.04% |
| 2003 Q2 | 568.15 Million USD | -4.96% |
| 2003 Q1 | 597.82 Million USD | -9.08% |
| 2002 Q2 | 719.86 Million USD | -1.44% |
| 2002 Q1 | 730.4 Million USD | 3.77% |
| 2002 Q3 | 1.36 Billion USD | 89.31% |
| 2002 Q4 | 657.49 Million USD | -51.75% |
| 2002 FY | 657.49 Million USD | -6.58% |
| 2001 Q3 | 734.73 Million USD | 40.19% |
| 2001 Q4 | 703.83 Million USD | -4.21% |
| 2001 Q2 | 524.1 Million USD | -0.21% |
| 2001 Q1 | 525.2 Million USD | 2.35% |
| 2001 FY | 703.83 Million USD | 37.16% |
| 2000 Q2 | 464.96 Million USD | 152.97% |
| 2000 FY | 513.12 Million USD | 189.74% |
| 2000 Q1 | 183.8 Million USD | 3.78% |
| 2000 Q4 | 513.12 Million USD | 3.88% |
| 2000 Q3 | 493.95 Million USD | 6.23% |
| 1999 Q2 | 140.2 Million USD | 2.19% |
| 1999 Q1 | 137.2 Million USD | -2.7% |
| 1999 FY | 177.1 Million USD | 25.6% |
| 1999 Q4 | 177.1 Million USD | 18.15% |
| 1999 Q3 | 149.9 Million USD | 6.92% |
| 1998 Q4 | 141 Million USD | -0.56% |
| 1998 Q1 | 148.6 Million USD | -0.73% |
| 1998 FY | 141 Million USD | -5.81% |
| 1998 Q2 | 145.8 Million USD | -1.88% |
| 1998 Q3 | 141.8 Million USD | -2.74% |
| 1997 Q3 | 73.6 Million USD | 9.69% |
| 1997 Q2 | 67.1 Million USD | 4.84% |
| 1997 FY | 149.7 Million USD | 131.02% |
| 1997 Q1 | 64 Million USD | -1.23% |
| 1997 Q4 | 149.7 Million USD | 103.4% |
| 1996 FY | 64.8 Million USD | 27.56% |
| 1996 Q2 | 59.6 Million USD | 0.0% |
| 1996 Q4 | 64.8 Million USD | 2.69% |
| 1996 Q3 | 63.1 Million USD | 5.87% |
| 1995 Q4 | 50.8 Million USD | 0.0% |
| 1995 FY | 50.8 Million USD | 296.88% |
| 1994 FY | 12.8 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -1499.898% |
| AngioDynamics, Inc. | 317.67 Million USD | -808.399% |
| AtriCure, Inc. | 613.93 Million USD | -370.039% |
| Avinger, Inc. | 13.77 Million USD | -20856.572% |
| BioLife Solutions, Inc. | 412.71 Million USD | -599.206% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 75.249% |
| Daxor Corporation | 34.86 Million USD | -8175.856% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -9878.975% |
| Femasys Inc. | 27.75 Million USD | -10296.809% |
| GlucoTrack, Inc. | 4.9 Million USD | -58732.212% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -2000.753% |
| Hologic, Inc. | 9.15 Billion USD | 68.483% |
| ICU Medical, Inc. | 4.37 Billion USD | 34.092% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 81.312% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -10039.218% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -732.152% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -46303.448% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -46303.448% |
| Masimo Corporation | 3.04 Billion USD | 5.122% |
| Microbot Medical Inc. | 8.32 Million USD | -34554.978% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -1578.571% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | -24.104% |
| Nephros, Inc. | 11.86 Million USD | -24229.483% |
| NovoCure Limited | 1.14 Billion USD | -151.78% |
| NEXGEL, Inc. | 9.95 Million USD | -28887.644% |
| NEXGEL, Inc. | 9.95 Million USD | -28887.644% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -987.035% |
| OraSure Technologies, Inc. | 482.84 Million USD | -497.649% |
| Pro-Dex, Inc. | 54.21 Million USD | -5223.224% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -4645.938% |
| Predictive Oncology Inc. | 14.41 Million USD | -19915.746% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -16962.571% |
| QuidelOrtho Corporation | 8.56 Billion USD | 66.301% |
| Repligen Corporation | 2.82 Billion USD | -2.171% |
| Sanara MedTech Inc. | 73.87 Million USD | -3806.424% |
| STAAR Surgical Company | 488.69 Million USD | -490.499% |
| Sharps Technology, Inc. | 11.78 Million USD | -24377.516% |
| Utah Medical Products, Inc. | 135.45 Million USD | -2030.343% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 60.845% |
| Jin Medical International Ltd. | 32.9 Million USD | -8670.266% |